Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanguard Health Care Index Fund ETF Shares (VHT)

Delayed Data
As of 6:30pm ET
 +0.25 / +0.18%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content


1 month+0.66% 3 years+10.06%
3 months+8.72% 5 years+17.41%
1 year+14.31% Since inception+9.38%
Data through 03/22/2017

Quote Details

Previous close$137.78
Open day’s range137.16 – 138.16
Net asset value (NAV)137.80 (03/21/2017)
Daily volume132,568
Average volume (3 months)297,742
Data as of 6:30pm ET, 03/22/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+17.41%+16.84%
Expense Gross exp ratio0.10%1.33%
Risk 5 year sharpe ratio1.351.11
Net assets$6.8B$3.0B
Average market cap$51.1B$30.5B
Average P/E22.922.3
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.97%
PFE Pfizer6.21%
MRK Merck5.45%
UNH UnitedHealth4.72%
AMGN Amgen3.94%
MDT Medtronic PLC3.38%
ABBV AbbVie3.01%
CELG Celgene2.87%
BMY Bristol-Myers Squibb2.84%
GILD Gilead Sciences2.79%